PT1007559E - Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso - Google Patents

Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso

Info

Publication number
PT1007559E
PT1007559E PT98945924T PT98945924T PT1007559E PT 1007559 E PT1007559 E PT 1007559E PT 98945924 T PT98945924 T PT 98945924T PT 98945924 T PT98945924 T PT 98945924T PT 1007559 E PT1007559 E PT 1007559E
Authority
PT
Portugal
Prior art keywords
bone morphogenetic
morphogenetic proteins
cells expressing
genetically modified
modified cells
Prior art date
Application number
PT98945924T
Other languages
English (en)
Inventor
Moutsatsos Ioannis
Dan Gazit
Yoram Zilberman
Gadi Turgeman
Original Assignee
Yissum Res Dev Co
Sity Of Jerusalem
Genetics Inst Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Sity Of Jerusalem, Genetics Inst Llc filed Critical Yissum Res Dev Co
Publication of PT1007559E publication Critical patent/PT1007559E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT98945924T 1997-09-05 1998-09-04 Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso PT1007559E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5798997P 1997-09-05 1997-09-05

Publications (1)

Publication Number Publication Date
PT1007559E true PT1007559E (pt) 2006-05-31

Family

ID=22013954

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98945924T PT1007559E (pt) 1997-09-05 1998-09-04 Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso

Country Status (12)

Country Link
US (2) US20020102728A1 (pt)
EP (1) EP1007559B1 (pt)
JP (1) JP2001514026A (pt)
AT (1) ATE314390T1 (pt)
AU (1) AU752556B2 (pt)
CA (1) CA2301882A1 (pt)
DE (1) DE69832989T2 (pt)
DK (1) DK1007559T3 (pt)
ES (1) ES2255180T3 (pt)
MX (1) MXPA00002318A (pt)
PT (1) PT1007559E (pt)
WO (1) WO1999011664A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039695A1 (en) * 2001-08-10 2003-02-27 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Collagen carrier of therapeutic genetic material, and method
US8858981B2 (en) 1997-10-10 2014-10-14 Ed. Geistlich Soehne Fuer Chemistrie Industrie Bone healing material comprising matrix carrying bone-forming cells
US20050186283A1 (en) 1997-10-10 2005-08-25 Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie Collagen carrier of therapeutic genetic material, and method
US9034315B2 (en) 1997-10-10 2015-05-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Cell-charged multi-layer collagen membrane
MXPA02000877A (es) * 1999-07-28 2002-08-06 Regeneration Tech Inc Matriz de hueso o cartilago como un vehiculo para suministro de acido nucleico.
US6939540B1 (en) 2000-07-31 2005-09-06 Cornell Research Foundation, Inc. Method of enhancing bone density
WO2003013588A1 (fr) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Materiau de regeneration de rein comprenant des cellules et un facteur de croissance cellulaire
JP4097544B2 (ja) * 2003-02-27 2008-06-11 独立行政法人理化学研究所 人工リンパ節
CA2531623A1 (en) * 2003-07-09 2005-01-20 Sdgi Holdings, Inc. Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation
US20050272678A1 (en) * 2004-02-11 2005-12-08 Bodine Peter Van N BMP-6 estrogen responsive element and methods of use thereof
US7531355B2 (en) * 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
US20120263692A1 (en) * 2009-11-16 2012-10-18 Bertone Alicia L Engineered Xenogeneic Cells for Repair of Biological Tissue
AU2016333996B2 (en) 2015-10-05 2020-05-28 Salk Institute For Biological Studies Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
AU2947395A (en) * 1995-06-06 1996-12-24 Human Genome Sciences, Inc. Bone morphogenic protein-10

Also Published As

Publication number Publication date
AU752556B2 (en) 2002-09-19
EP1007559A1 (en) 2000-06-14
US20110111505A1 (en) 2011-05-12
MXPA00002318A (es) 2006-02-22
ES2255180T3 (es) 2006-06-16
ATE314390T1 (de) 2006-01-15
DE69832989T2 (de) 2006-08-24
DK1007559T3 (da) 2006-05-08
CA2301882A1 (en) 1999-03-11
WO1999011664A1 (en) 1999-03-11
JP2001514026A (ja) 2001-09-11
US20020102728A1 (en) 2002-08-01
DE69832989D1 (de) 2006-02-02
EP1007559B1 (en) 2005-12-28
AU9306298A (en) 1999-03-22

Similar Documents

Publication Publication Date Title
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
ATE391778T1 (de) Mutanten des vaskulären, endothelzellen- spezifischen wachstumsfaktors c (vegf-c) und deren verwendungen
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
IL117425A0 (en) Receptor activation by gas6
DE69831741D1 (de) Modifizierte adenovirale fiber und sie enthaltende adenoviren
DE69829858D1 (de) System zum verankern von gewebe an knochen
ES2121479T3 (es) Solucion estabilizadora para proteinas y peptidos.
DK0814827T3 (da) Karendotel-vækstfaktor-B
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
DK1003545T3 (da) Heparin-bindende vækstfaktor (HBGF)-polypeptider
DK0973794T3 (da) Netrinreceptorer
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
WO2002050111A3 (en) Isolated laminin 10
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ZA985090B (en) CNS neuroregenerative compositions and methods of use
EA200000270A1 (ru) КОМПОЗИЦИИ ДЛЯ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ СЕКРЕТИРУЕМЫЕ БЕЛКИ, ТАКИЕ КАК β-ИНТЕРФЕРОН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
BR0211130A (pt) Plantas transgênicas que expressam proteìnas de ligação da cobalamina
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
DE69828972D1 (de) TNF inhibierendes Protein TIP-B1 und dessen Verwendung
ATE412764T1 (de) Genetische transduktion von hämatopoietische vorläuferzellen